Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA.
Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):547-57. doi: 10.1158/1055-9965.EPI-09-0869. Epub 2010 Jan 19.
Prostaglandins are important inflammatory mediators; prostaglandin E2 (PGE2) is the predominant prostaglandin in colorectal neoplasia and affects colorectal carcinogenesis. Prostaglandins are metabolites of omega-6 and omega-3 polyunsaturated fatty acids; their biosynthesis is the primary target of nonsteroidal anti-inflammatory drugs (NSAID), which reduce colorectal neoplasia risk.
We investigated candidate and tagSNPs in PGE2 synthase (PGES), PGE2 receptors (EP2 and EP4), and prostaglandin dehydrogenase (PGDH) in a case-control study of adenomas (n = 483) versus polyp-free controls (n = 582) and examined interactions with NSAID use or fish intake, a source of omega-3 fatty acids.
A 30% adenoma risk reduction was observed for EP2 4950G>A (intron 1; OR(GA/AA vs. GG), 0.71; 95% confidence interval, 0.52-0.99). For the candidate polymorphism EP4 Val294Ile, increasing fish intake was associated with increased adenoma risk among those with variant genotypes, but not among those with the Val/Val genotype (P(interaction) = 0.02). An interaction with fish intake was also observed for PGES -664A>T (5' untranslated region; P(interaction) = 0.01). Decreased risk with increasing fish intake was only seen among those with the AT or TT genotypes (OR(>2 t/wk vs. <1 t/wk), 0.56; 95% confidence interval, 0.28-1.13). We also detected interactions between NSAIDs and EP2 9814C>A (intron 1) and PGDH 343C>A (intron 1). However, none of the observed associations was statistically significant after adjustment for multiple testing. We investigated potential gene-gene interactions using the Chatterjee 1 degree of freedom Tukey test and logic regression; neither method detected significant interactions.
These data provide little support for associations between adenoma risk and genetic variability related to PGE(2), yet suggest gene-environment interactions with anti-inflammatory exposures.
前列腺素是重要的炎症介质;前列腺素 E2(PGE2)是结直肠肿瘤中的主要前列腺素,影响结直肠癌变。前列腺素是 ω-6 和 ω-3 多不饱和脂肪酸的代谢产物;它们的生物合成是非甾体抗炎药(NSAID)的主要靶点,可降低结直肠肿瘤的风险。
我们在腺瘤(n=483)与无息肉对照(n=582)的病例对照研究中,研究了 PGE2 合酶(PGES)、PGE2 受体(EP2 和 EP4)和前列腺素脱氢酶(PGDH)中的候选和标签单核苷酸多态性(SNP),并检查了它们与 NSAID 使用或鱼类摄入(ω-3 脂肪酸的来源)的相互作用。
观察到 EP2 4950G>A(内含子 1;OR(GA/AA 与 GG),0.71;95%置信区间,0.52-0.99)的腺瘤风险降低 30%。对于候选多态性 EP4 Val294Ile,增加鱼类摄入量与变异基因型个体的腺瘤风险增加相关,但 Val/Val 基因型个体则不相关(P(交互作用)=0.02)。PGES-664A>T(5'非翻译区;P(交互作用)=0.01)也观察到与鱼类摄入的相互作用。仅在 AT 或 TT 基因型个体中观察到随着鱼类摄入增加而风险降低(OR(>2 次/周与<1 次/周),0.56;95%置信区间,0.28-1.13)。我们还检测到 NSAIDs 与 EP2 9814C>A(内含子 1)和 PGDH 343C>A(内含子 1)之间的相互作用。然而,在进行多次检验校正后,观察到的关联均无统计学意义。我们使用 Chatterjee 1 自由度 Tukey 检验和逻辑回归法研究了潜在的基因-基因相互作用;两种方法均未检测到显著的相互作用。
这些数据几乎没有提供支持与 PGE(2)相关的腺瘤风险和遗传变异之间的关联的证据,但提示与抗炎暴露的基因-环境相互作用。